ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1610

New Autoantigens Associated with Lupus Nephritis

Sachiko Onishi1, Yuki Tanaka2, Tatsuhiko Miyazaki3, Jun Ishizaki1, Takuya Matsumoto1, Endy Adnan1, Hitoshi Yamasaki4, Koichiro Suemori1, Takafumi Okura5, Masaki Yasukawa1 and Hitoshi Hasegawa6, 1Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, Japan, 2Integrated Center for Sciences, Ehime University, Toon, Japan, 3Division of Pathology, Gifu University Hospital, Gifu, Japan, 4Department of Hematology, Clinical Immunology, and Infectious Disease, Ehime University Graduate School of Medicine, Toon, Japan, 5Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Toon, Japan, 6Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: autoantigens, lupus nephritis and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Autoimmune Disease Transition, Disease Subsets and Prediction of Flares, Cytokines and Autoantibodies

Session Type: Abstract Submissions (ACR)

[Background/Purpose ] Systemic lupus erythematosus (SLE) is characterized by the production of a variety of autoantibodies and is considered a prototype immune complex disease. Anti-dsDNA antibodies contribute to the pathogenesis of lupus nephritis (LN). However, since anti-dsDNA antibodies are not sufficient for the diagnosis, prognosis or evaluation of disease activity, other autoantibodies associated with LN need to be identified. Using an N-terminal biotinylated protein library (BPL) we screened for autoantigens reacting with LN patient sera and then further characterize these autoantigens.
[Methods ] We screened for autoantigens using the AlphaScreen method with the sera from 3 SLE patients with different disease complications; thrombocytopenia, nephritis or serositis. Antigens used for screening were created using the 2296 cDNA library from a wheat cell-free protein production system in the Ehime University Cell-Free Sciences and Technology Research Center. The proteins characteristic of nephritis were selected, and immunoprecipitation was performed using serum from patients with LN. Immunohistochemical staining of renal tissues was carried out with antibodies against proteins positive in the immunoprecipitation. The specificity of the identified autoantigens was analyzed by an enzyme-linked immunosorbent assay (ELISA) with serum from approximately 250 patients with various autoimmune diseases such as polymiositis/dermatomyositis, systemic sclerosis, and rheumatoid arthritis.
 [Results ] We screened 66 proteins which reacted with LN patient sera at a high levels. Of these, ten proteins showed strong reaction specifically to SLE sera with immunoprecipitation.  Immune complex deposition of these ten proteins was confirmed by immunohistochemical staining of renal biopsy tissue and autopsy renal tissue of LN. Clear deposition of 2 proteins, ribosomal RNA processing 8 (RRP8) and transition protein 1 (TNP1), was seen in some renal tissues. ELISA analysis showed that RRP8 and TNP1 reacted to the sera from some SLE patients but have little or no reaction with those from other autoimmune diseases. In addition, anti-RRP8 and anti-TNP1 antibodies were detected in 5 and 7 out of 11 LN patients, respectively.
[Conclusion ] The AlphaScreen method using BPL created by wheat germ cell-free protein synthesis proved to be useful for autoantibody screening. We have identified RRP8 and TNP1 as new LN autoantigens. RRP8 and TNP1 may play an important role in the pathogenesis of LN.


Disclosure:

S. Onishi,
None;

Y. Tanaka,
None;

T. Miyazaki,
None;

J. Ishizaki,
None;

T. Matsumoto,
None;

E. Adnan,
None;

H. Yamasaki,
None;

K. Suemori,
None;

T. Okura,
None;

M. Yasukawa,
None;

H. Hasegawa,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/new-autoantigens-associated-with-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology